ArticleJournal of manufacturing systems2021
Role of additive manufacturing in medical application COVID-19 scenario: India case study.
Article in Journal of manufacturing systems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Additive manufacturing for biomedical applications: a review on classification, energy consumption, and its appreciable role since COVID-19 pandemic.Progress in additive manufacturing · 2022Review
- Medical-Grade Polyamide 12 Nanocomposite Materials for Enhanced Mechanical and Antibacterial Performance in 3D Printing Applications.Polymers · 2022Article
- Affordable Biocidal Ultraviolet Cured Cuprous Oxide Filled Vat Photopolymerization Resin Nanocomposites with Enhanced Mechanical Properties.Biomimetics (Basel, Switzerland) · 2022Article
- Investigation of the Biocidal Performance of Multi-Functional Resin/Copper Nanocomposites with Superior Mechanical Response in SLA 3D Printing.Biomimetics (Basel, Switzerland) · 2022Article
- Mechanical response assessment of antibacterial PA12/TiOThe International journal, advanced manufacturing technology · 2022Article
- How is COVID-19 altering the manufacturing landscape? A literature review of imminent challenges and management interventions.Annals of operations research · 2021Article
- New IT driven rapid manufacturing for emergency response.Journal of manufacturing systems · 2021Article
- Community-driven PPE production using additive manufacturing during the COVID-19 pandemic: Survey and lessons learned.Journal of manufacturing systems · 2021Article
- A literature survey of the robotic technologies during the COVID-19 pandemic.Journal of manufacturing systems · 2021Article
- Case study into the successful emergency production and certification of a filtering facepiece respirator for Belgian hospitals during the COVID-19 pandemic.Journal of manufacturing systems · 2021Article
- Additive manufacturing and the COVID-19 challenges: An in-depth study.Journal of manufacturing systems · 2021Article
- Applications of additive manufacturing (AM) in sustainable energy generation and battle against COVID-19 pandemic: The knowledge evolution of 3D printing.Journal of manufacturing systems · 2021Review
- Additively manufactured respirators: quantifying particle transmission and identifying system-level challenges for improving filtration efficiency.Journal of manufacturing systems · 2021Article
- Impact of COVID-19 on IoT Adoption in Healthcare, Smart Homes, Smart Buildings, Smart Cities, Transportation and Industrial IoT.Sensors (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper reviews how the Additive Manufacturing (AM) industry played a key role in stopping the spread of the Coronavirus by providing customized parts on-demand quickly and locally, reducing waste and eliminating the need for an extensive manufacturer. The AM technology uses digital files for the production of crucial medical parts, which has been proven essential during the COVID-19 crisis. Going ahead, the 3D printable clinical model resources described here will probably be extended in various centralized model storehouses with new inventive open-source models. Government agencies, individuals, corporations and universities are working together to quickly development of various 3D-printed products especially when established supply chains are under distress, and supply cannot keep up with demand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.